Called orforglipron, the results of a new clinical trial announced Thursday by manufacturer Eli Lilly suggest that the pill could be a breakthrough in a class of drugs called GLP-1 agonists ...

Eric Deggans is NPR's first full-time TV critic, also serving as media analyst and guest host for the network. Deggans came to NPR in 2013 from the Tampa Bay Times, where he served as TV/Media ...

Work alongside individuals, families, organizations and communities to help them lead happy, healthy lives.